ilShinbiobase Co. Ltd. (KOSDAQ:068330)

ilShinbiobase Statistics

Total Valuation

ilShinbiobase has a market cap or net worth of KRW 61.56 billion.

Market Cap	61.56B
Enterprise Value	n/a

Important Dates

The last earnings date was Friday, May 16, 2025.

Earnings Date	May 16, 2025
Ex-Dividend Date	Dec 27, 2024

Share Statistics

ilShinbiobase has 41.68 million shares outstanding.

Current Share Class	41.68M
Shares Outstanding	41.68M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	32.82%
Owned by Institutions (%)	n/a
Float	28.00M

Valuation Ratios

The trailing PE ratio is 15.95.

PE Ratio	15.95
Forward PE	n/a
PS Ratio	3.36
PB Ratio	1.45
P/TBV Ratio	1.45
P/FCF Ratio	18.51
P/OCF Ratio	14.42
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 5.24

Current Ratio	5.24
Quick Ratio	3.80
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is 8.06% and return on invested capital (ROIC) is 5.62%.

Return on Equity (ROE)	8.06%
Return on Assets (ROA)	4.83%
Return on Invested Capital (ROIC)	5.62%
Return on Capital Employed (ROCE)	8.49%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.39
Inventory Turnover	1.21

Taxes

In the past 12 months, ilShinbiobase has paid 1.02 billion in taxes.

Income Tax	1.02B
Effective Tax Rate	23.59%

Stock Price Statistics

The stock price has increased by +25.25% in the last 52 weeks. The beta is 1.06, so ilShinbiobase's price volatility has been similar to the market average.

Beta (5Y)	1.06
52-Week Price Change	+25.25%
50-Day Moving Average	1,624.04
200-Day Moving Average	1,388.28
Relative Strength Index (RSI)	32.17
Average Volume (20 Days)	172,109

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, ilShinbiobase had revenue of KRW 18.34 billion and earned 3.96 billion in profits. Earnings per share was 92.62.

Revenue	18.34B
Gross Profit	8.45B
Operating Income	3.68B
Pretax Income	4.31B
Net Income	3.96B
EBITDA	4.25B
EBIT	3.68B
Earnings Per Share (EPS)	92.62

Balance Sheet

The company has 19.03 billion in cash and n/a in debt, giving a net cash position of 19.03 billion or 456.69 per share.

Cash & Cash Equivalents	19.03B
Total Debt	n/a
Net Cash	19.03B
Net Cash Per Share	456.69
Equity (Book Value)	42.38B
Book Value Per Share	1,014.01
Working Capital	26.02B

Cash Flow

In the last 12 months, operating cash flow was 4.27 billion and capital expenditures -943.94 million, giving a free cash flow of 3.33 billion.

Operating Cash Flow	4.27B
Capital Expenditures	-943.94M
Free Cash Flow	3.33B
FCF Per Share	79.81

Margins

Gross margin is 46.07%, with operating and profit margins of 20.06% and 21.58%.

Gross Margin	46.07%
Operating Margin	20.06%
Pretax Margin	23.51%
Profit Margin	21.58%
EBITDA Margin	23.20%
EBIT Margin	20.06%
FCF Margin	18.14%

Dividends & Yields

This stock pays an annual dividend of 7.00, which amounts to a dividend yield of 0.47%.

Dividend Per Share	7.00
Dividend Yield	0.47%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	7.58%
Buyback Yield	0.97%
Shareholder Yield	1.43%
Earnings Yield	6.43%
FCF Yield	5.40%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

The last stock split was on January 24, 2014. It was a forward split with a ratio of 5.

Last Split Date	Jan 24, 2014
Split Type	Forward
Split Ratio	5

Scores

ilShinbiobase has an Altman Z-Score of 12.73 and a Piotroski F-Score of 4.

Altman Z-Score	12.73
Piotroski F-Score	4